Enter assignee name

EPO Patents = 4

Trademarks = 1

Forward Citations = 131

Loading Chart...

4 inventors (with patents filed for the assignee):

Jean-Pierre Sommadossi (24 out of 74 patents)

Adel M Moussa (24 out of 61 patents)

Xiao-Jian Zhou (2 out of 2 patents)

4. Keith M Pietropaolo (2 out of 2 patents)

5. Jean-Pierre Sommadossi (0 patent)

24 patents: Sort by Forward Citations

1. 12458656 - Advantageous anti-HCV combination therapy (2025-11-04),

2. 12226429 - Highly active compounds against COVID-19 (2025-02-18),

3. 12084473 - β-D-2'-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N6-substituted purine nucleotides for HCV treatment (2024-09-10),

4. 12006340 - Nucleotide hemi-sulfate salt for the treatment of hepatitis c virus (2024-06-11),

5. 11975016 - 2′-substituted-N-substituted purine nucleotides for RNA virus treatment (2024-05-07),

6. 11813278 - Highly active compounds against COVID-19 (2023-11-14),

7. 11738038 - Highly active compounds against COVID-19 (2023-08-29),

8. 11707480 - Highly active compounds against COVID-19 (2023-07-25),

9. 11690860 - Treatment of HCV infected patients with cirrhosis (2023-07-04),

10. 10946033 - 2'-substituted-N6-substituted purine nucleotides for RNA virus treatment (2021-03-16),

11. 10906928 - Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus (2021-02-02),

12. 10894804 - Nucleotide hemi-sulfate salt for the treatment of hepatitis C virus (2021-01-19),

13. 10875885 - β-d-2'-deoxy-2′-α-fluoro-2′-β-c-substituted-2-modified-n-substituted purine nucleotides for HCV treatment (2020-12-29),

14. 10874687 - Highly active compounds against COVID-19 (2020-12-29),

15. 10870673 - β-D-2'-deoxy-2′-α-fluoro-2′-β-C-substituted-2-modified-N-substituted purine nucleotides for HCV treatment (2020-12-22),

Atea Pharmaceuticals, Inc. is a leading biopharmaceutical company focused on discovering and developing innovative antiviral therapeutics to improve the lives of patients affected by life-threatening viral diseases. With a commitment to address unmet medical needs, Atea aims to revolutionize the treatment landscape through its cutting-edge research and development efforts.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

24 Patents

#101 in Boston, MA

#800 in Massachusetts

#13,427 in US

#25,861 in the World

Boston, MA, United States of America

Atea Pharmaceuticals, Inc.